These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis. Choi EY; Kim D; Hong BK; Kwon HM; Song YG; Byun KH; Park HY; Whang KC; Kim HS Exp Mol Med; 2002 Dec; 34(6):391-400. PubMed ID: 12526080 [TBL] [Abstract][Full Text] [Related]
6. Chlamydia pneumoniae and atherosclerosis: the role of mast cells. Di Pietro M; Schiavoni G; Del Piano M; Shaik Y; Boscolo P; Caraffa A; Grano M; Teté S; Conti F; Sessa R J Biol Regul Homeost Agents; 2009; 23(2):65-9. PubMed ID: 19589286 [TBL] [Abstract][Full Text] [Related]
8. [Chlamydia pneumoniae--chronic infection and atherosclerosis]. Tiran B Wien Med Wochenschr; 2001; 151(24):590-3. PubMed ID: 11820175 [TBL] [Abstract][Full Text] [Related]
9. Chlamydia pneumoniae and cardiovascular disease. Campbell LA; Kuo CC; Grayston JT Emerg Infect Dis; 1998; 4(4):571-9. PubMed ID: 9866733 [TBL] [Abstract][Full Text] [Related]
10. Chlamydia pneumoniae and multiple infections in the aorta contribute to atherosclerosis. Shi Y; Tokunaga O Pathol Int; 2002 Dec; 52(12):755-63. PubMed ID: 12588444 [TBL] [Abstract][Full Text] [Related]
11. Chlamydia pneumoniae and atherosclerosis: current state and future prospectives. Sessa R; Nicoletti M; Di Pietro M; Schiavoni G; Santino I; Zagaglia C; Del Piano M; Cipriani P Int J Immunopathol Pharmacol; 2009; 22(1):9-14. PubMed ID: 19309547 [TBL] [Abstract][Full Text] [Related]
13. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. Grayston JT J Infect Dis; 2000 Jun; 181 Suppl 3():S402-10. PubMed ID: 10839724 [TBL] [Abstract][Full Text] [Related]
14. [Chlamydia pneumoniae and atherosclerosis]. Fortini A; Corti G; Cappelletti C Ann Ital Med Int; 1999; 14(4):253-63. PubMed ID: 10638018 [TBL] [Abstract][Full Text] [Related]
15. [Effect of Chlamydia pneumoniae infection on carotid atherosclerosis development]. Kaźmierski R; Kozubski W Neurol Neurochir Pol; 2002; 36(1):131-42. PubMed ID: 12053604 [TBL] [Abstract][Full Text] [Related]
16. [Infection and coronary atherosclerosis: the role Chlamydia pneumonia]. Paz M; de Otero J; Codinach P; Ferrer-Ruscalleda F; Gayà M; Ibernón M Rev Esp Cardiol; 1998 Nov; 51(11):857-63. PubMed ID: 9859707 [TBL] [Abstract][Full Text] [Related]
18. Chlamydia pneumoniae, strain TWAR and atherosclerosis. Grayston JT; Kuo CC; Campbell LA; Benditt EP Eur Heart J; 1993 Dec; 14 Suppl K():66-71. PubMed ID: 8131792 [TBL] [Abstract][Full Text] [Related]
19. Infection with Chlamydia pneumoniae and atherosclerosis: a review. Movahed MR J S C Med Assoc; 1999 Aug; 95(8):303-8. PubMed ID: 10478518 [TBL] [Abstract][Full Text] [Related]
20. In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells. Quinn TC; Gaydos CA Am Heart J; 1999 Nov; 138(5 Pt 2):S507-11. PubMed ID: 10539860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]